The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The shifting landscape of pancreatic cancer research funding.
Carlyn Rose Co Tan
No relevant relationships to disclose
Rhonda Aizenberg
No relevant relationships to disclose
Lynne Davies
No relevant relationships to disclose
Lynn Matrisian
No relevant relationships to disclose
Xiao Zhang
No relevant relationships to disclose
Richard Tuli
No relevant relationships to disclose
Andrew Eugene Hendifar
No relevant relationships to disclose